Overview

Pemetrexed for the Treatment of Chordoma

Status:
Recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and tolerability of pemetrexed administered to people with chordoma. Other purposes of this study are to: - find out side effects (good and bad) of pemetrexed; - learn more about how pemetrexed might affect the growth of cancer cells; - evaluate tumor characteristics by collecting tumor tissue samples if available; - look at biomarkers (biochemical features that can be used to measure the progress of disease or the effects of a drug) in blood and cerebrospinal fluid if available.
Phase:
Phase 1
Details
Lead Sponsor:
John Wayne Cancer Institute
Collaborators:
Chordoma Foundation
Eli Lilly and Company
Treatments:
Pemetrexed